Dr. Diamandis currently serves as Division Head of Clinical Biochemistry at Mount Sinai Hospital and Biochemist-in-Chief at the University Health Network and is Professor & Head, Clinical Biochemistry, Department of Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada.

Dr. Diamandis received his B.Sc. in Chemistry, Ph.D. in Analytical Chemistry and M.D. from the University of Athens, Greece and a Diploma in Clinical Biochemistry from the University of Toronto, Canada. He is a Certified Clinical Chemist by the Canadian Academy of Clinical Biochemistry and the American Board of Clinical Chemistry.

Dr. Diamandis is a Member of 45 Journal Advisory Scientific and Editorial Boards, including The Journal of Biological Chemistry, Cancer Research, Molecular Cancer Research, Journal of Clinical Oncology, Clinical Chemistry and Journal of Proteome Research. He has received numerous awards from both national and international organizations. Dr. Diamandis is highlighted for his citation record in the Provincial Government of Ontario document entitled “Ontario’s Innovation Agenda” (2010). He has more than 36,000 lifetime citation and an h-index of 97.
Dr. Diamandis' research activities evolve around discovery and validation of cancer biomarkers, proteomics, mass spectrometry and translational research, and include the following:
  • Kallikrein Biology and Pathophysiology
  • Proteomics
  • Tumour Markers
  • Mechanisms of Carcinogenesis and Metastatic Progression
  • Translational Research
  • Cancer Therapeutics
  • Male Infertility
  • Pathobiology and Biomarkers of Autoimmune Diseases
  • Neurodegeneration

For a list of Dr. Diamandis's publications, please visit PubMed, Scopus or ORCID.